Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register for free online access

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text Free
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Clarke, C. J.
Right arrow Articles by Haselden, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, C. J.
Right arrow Articles by Haselden, J. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Articles

Metabolic Profiling as a Tool for Understanding Mechanisms of Toxicity

Christopher J. Clarke and John N. Haselden

Novartis Pharma AG, Basel, Switzerland

Correspondence: Address correspondence to: Dr. Christopher J. Clarke, Novartis Pharma AG, Preclinical Safety, WKL-105.4.21, CH-4002 Basel, Switzerland; email: christopher.clarke{at}novartis.com.

Metabolic profiling (metabolomics/metabonomics) is the measurement in biological systems of the complement of low-molecular-weight metabolites and their intermediates that reflects the dynamic response to genetic modification and physiological, pathophysiological, and/or developmental stimuli. The measurement and interpretation of the endogenous metabolite profile from a biological sample (typically urine, serum, or biological tissue extract) have provided many opportunities to investigate the changes induced by external stimuli (e.g., drug treatment) or enhance our knowledge of inherent biological variation within subpopulations. This article will focus on the basic principles of metabolic profiling and how the tools (nuclear magnetic resonance [NMR], liquid chromatography–mass spectrometry [LC-MS]) can be applied in toxicology and pathology. Metabolic profiling can complement conventional methodologies and other "omics" technologies in investigating preclinical drug development issues. Case studies will illustrate the value of metabolic profiling in improving our understanding of phospholipidosis and peroxisome proliferation. A key message will be that metabolic profiling offers huge potential to highlight biomarkers and mechanisms in support of toxicology and pathology investigations in preclinical drug development.

Key Words: Metabonomics • preclinical safety assessment/risk management • pathobiology • biochemistry • biomarkers

Abbreviations: ACMSD, amino-carboxy-muconate-semialdehydedecarboxylase • CAD, cationic amphiphilic drug • CCR5, chemokine receptor 5 • CSF, cerebrospinal fluid • GC, gas chromatography • HP, high performance • HPLC, high performance liquid chromatography • LBPA, lyso-bis phosphatidic acid • LC, liquid chromatography • MS, mass spectrometry • NMN, N-methyl-nicotinamide • NMR, nuclear magnetic resonance • PAG, phenyl acetyl glycine • PCA, principal component analysis • PP, peroxisome proliferation • PPAR, peroxisome proliferator activated receptor • QAPRT, quinolate phosphorlbosyl-transferase • RT, real time • RT-PCR, reverse transcriptase polymerase chain reaction • TSP, 1,1,2,2-d4 trimethylsilylproprionate • UP, ultra performance • 4PY, N-methyl-4-pyridone-3-carboxamide

Toxicologic Pathology, Vol. 36, No. 1, 140-147 (2008)
DOI: 10.1177/0192623307310947


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?